Search

Your search keyword '"La Rosa, C."' showing total 769 results

Search Constraints

Start Over You searched for: Author "La Rosa, C." Remove constraint Author: "La Rosa, C."
769 results on '"La Rosa, C."'

Search Results

2. Access to and quality of elective care: a prospective cohort study using hernia surgery as a tracer condition in 83 countries

4. Exploring manufacturability of novel 2D channel materials: 300 mm wafer-scale 2D NMOS & PMOS using MoS2, WS2, & WSe2

6. Enhancing dielectric passivation on monolayer WS2 via a sacrificial graphene oxide seeding layer.

8. Integration of epitaxial monolayer MX₂ channels on 300mm wafers via Collective-Die-To-Wafer (CoD2W) transfer

14. 165P SCLC subtypes are associated with distinct dinicopathological features and outcomes: A biomarker analysis from the CANTABRICO study

18. Validation and Meaningful Change Thresholds for an Objective Cough Frequency Measurement in Chronic Cough

20. PL03.12 Progression Free Survival and Overall Survival in NADIM II Study

21. MA06.03 Pre-treatment ctDNA Levels Significantly Predicts of OS and PFS in NADIM II Trial

22. 848P Second-line systemic treatment for patients with advanced melanoma: Results from the prospective real-world study GEM1801

23. 1532P Phase IIIb study of durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Preliminary efficacy results

24. 802P Demography and clinical outcomes of adjuvant therapy in Spain: Results from GEM 1801 study

25. 863P Elderly patients (pts) with advanced melanoma: Results from the prospective real-world study GEM1801

26. 1227P Update on the analysis of operability parameter changes in neoadjuvant treatment with chemotherapy and anti-PD-1/PD-L1

29. Metal Binding to Prion Protein

30. Arecibo Observatory for All

32. Liquid Memory and the Future of Data Storage

35. 142P Phase IIIb study of durvalumab plus platinum–etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab

38. Paediatric cerebral palsy and undernutrition: compromises are needed

39. 140P Preliminary results from PROPEL: A phase I/II study of bempegaldesleukin (BEMPEG: NKTR-214) plus pembrolizumab (PEMBRO) with or without chemotherapy in patients with metastatic NSCLC

40. Interventions for poor nutritional status in paediatric cp: results from a Delphi panel

42. INCIDENCIA TEST GESTÁLTICO VISOMOTOR DE BENDER KOPPITZ EN EL APRENDIZAJE DEL LENGUAJE SIMBÓLICO.

43. P59 Baseline characteristics and medical history of patients with refractory or unexplained chronic cough participating in two global phase 3 clinical trials

45. P60 Patient-reported improvements with gefapixant, a P2X3-receptor antagonist, over 52 weeks in two phase 3 clinical trials for refractory or unexplained chronic cough

46. 1667TiP Durvalumab plus platinum-etoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): A Spanish phase IIIb single arm, real-world study

47. 1038MO Intracranial activity of encorafenib and binimetinib followed by radiotherapy in patients with BRAF mutated melanoma and brain metastasis: Preliminary results of the GEM1802/EBRAIN-MEL phase II clinical trial

49. 1056P Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study

50. 1364TiP Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy

Catalog

Books, media, physical & digital resources